AlloVir Statistics

Share Statistics

AlloVir has 5.04M shares outstanding. The number of shares has increased by 2.8% in one year.

Shares Outstanding	5.04M
Shares Change (YoY)	2.8%
Shares Change (QoQ)	0%
Owned by Institutions (%)	1.43%
Shares Floating	873.06K
Failed to Deliver (FTD) Shares	1
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 57.02K, so 0% of the outstanding shares have been sold short.

Short Interest	57.02K
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.25

Valuation Ratios

The PE ratio is -0.82 and the forward PE ratio is -0.97. AlloVir's PEG ratio is 0.01.

PE Ratio	-0.82
Forward PE	-0.97
PS Ratio	0
Forward PS	0.3
PB Ratio	0.42
P/FCF Ratio	-0.71
PEG Ratio	0.01

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for AlloVir.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 22.63, with a Debt / Equity ratio of 0.

Current Ratio	22.63
Quick Ratio	22.63
Debt / Equity	0
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	n/a
Profits Per Employee	$-9.79M
Employee Count	6
Asset Turnover	0
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by -40% in the last 52 weeks. The beta is 0.62, so AlloVir's price volatility has been higher than the market average.

Beta	0.62
52-Week Price Change	-40%
50-Day Moving Average	9.78
200-Day Moving Average	14.77
Relative Strength Index (RSI)	50.86
Average Volume (20 Days)	22,940

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-65.44M
Net Income	-58.77M
EBITDA	-65.44M
EBIT	n/a
Earnings Per Share (EPS)	-11.73

Full Income Statement

Balance Sheet

The company has 118.29M in cash and 0 in debt, giving a net cash position of 118.29M.

Cash & Cash Equivalents	118.29M
Total Debt	n/a
Net Cash	n/a
Retained Earnings	-714.96M
Total Assets	103.09M
Working Capital	95.04M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -67.7M and capital expenditures 0, giving a free cash flow of -67.7M.

Operating Cash Flow	-67.7M
Capital Expenditures	n/a
Free Cash Flow	-67.7M
FCF Per Share	-13.64

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ALVR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for ALVR.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on Jan 16, 2025. It was a backward split with a ratio of 1:23.

Last Split Date	Jan 16, 2025
Split Type	backward
Split Ratio	1:23

Scores

Altman Z-Score	-1.19
Piotroski F-Score	1

AlloVir Inc. (ALVR)